KATY DODT: Open Payments
NPI 1710609128 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,820 in 95 payments from 20 companies in 2025. Trend: 2023 $1,072 · 2024 $1,887 · 2025 $1,820
Food & beverage: $1,788Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $425 |
| Novo Nordisk Inc | 15 | $292 |
| AstraZeneca Pharmaceuticals LP | 3 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $207 |
| Astellas Pharma US Inc | 5 | $112 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Lilly USA, LLC | 4 | $72 |
| PFIZER INC. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| TOLMAR, INC. | 3 | $50 |
Products named: CAPLYTA, QULIPTA, AIRSUPRA, VRAYLAR, Ozempic, FARXIGA, Veozah, Wegovy.
Industry payments across AZ — which companies pay providers there.
